![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() By Olivier THIBAULT Paris (AFP) March 22, 2020
Like a giant tidal wave, the COVID-19 pandemic is battering the health systems of several European countries, leaving experts scrambling to know when it will reach its peak. What will the aftermath of this "tsunami", as Italian health workers have called it, be like? A general receding and a return to normality, or regular recurrences that will overwhelm hospitals? - Calm before the storm? - The wave seems to have already subsided in China, where the novel coronavirus first broke out late last year: over recent days no new local cases have been recorded. But French public health specialist and epidemiologist Antoine Flahault in the Lancet medical journal wonders if the worse is not yet to come. China could so far have "experienced a herald wave, to use terminology borrowed from those who study tsunamis, and is the big wave still to come?" he wrote. To understand the complexity of how epidemics evolve it is necessary to go back to the post World War I period, when in three waves the Spanish Flu killed nearly 50 million people -- more than the Great War itself. Then it disappeared. The question of why has tormented mathematicians. In the late 1920's Scotland's William Ogilvy Kermack and Anderson Gray McKendrick developed models in a bid to understand the dynamics of epidemics. - Immunity threshold - Kermack and McKendrick discovered that an epidemic does not end because it runs out of vulnerable people, but because as the number of infections increases a so-called "herd immunity" threshold is reached. "Herd immunity is the proportion of people immunised against the virus (either through infection or vaccination when it exists) that needs to be achieved to stop any risk of resurgence", said Flahault, head of Geneva University's Institute of Global Health. That proportion depends on the ease with which the virus is transmitted from an infected to a healthy person. The more contagious the disease, the higher the number of immunised people has to be to stop it in its tracks. For COVID-19 "there would need to be between 50 and 66 percent of people infected and then rendered immune to wipe out the pandemic", he said. The level of contagion itself is open to variation, according to the kind of preventative measures taken, such as quarantine, confinement, and also potentially weather conditions. If an infected person infects on average less than one other person "then the epidemic comes to an end", he said. - 'Resurgences' - But that will not necessarily be an end of the epidemic, which might just be taking a break, as he argues it is "currently doing in China and South Korea". Because health measures during an epidemic are only temporary "and when you relax them the epidemic starts again until it reaches an ad-hoc herd immunity, sometimes over several months or years," he said. The head of the infectious diseases service at the Pitie Salpetriere hospital in Paris, Professor Francois Bricaire, also warned of possible "resurgences". "The reappearance of COVID-19 is a possibility, with eventually a seasonal resurgence" he told AFP. Sharon Lewin, an Australian infectious diseases expert, also wonders about the possibility of a return: "Will it come back? We don't know." However, she said SARS (Severe Acute Respiratory Syndrome), also a coronavirus, disappeared completely following strict social distancing measures, after killing 774 people in 2002 and 2003. The development of a vaccine and its global distribution, which the pharmaceutical industry has promised to deliver within 12-18 months, would radically change the outlook.
![]() ![]() Fujifilm shares soar after China backs drug to treat virus Tokyo (AFP) March 18, 2020 Shares in Japanese firm Fujifilm Holdings sky-rocketed on Wednesday after Chinese authorities said a drug produced by the company could be effective for treating coronavirus patients. Fujifilm Holdings stock started the day untraded because of a glut of buy orders, before soaring 15.4 percent to 5,238 yen, the highest level allowed during trade for the day. China's ministry of science and technology said late Tuesday that some clinical trials have been completed on favipiravir - the main ingred ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |